Skip to main content
. 2018 Mar 25;2018:4702481. doi: 10.1155/2018/4702481

Figure 5.

Figure 5

The FR3 acted on PARPc/PARP cell death marker proteins, caspase-3c/caspase-3, and caspase-8c/caspase-8 in 24-hour treated HeLa cells. The concentrations used were 15 μg/mL, 25 μg/mL, and 40 μg/mL FR3 and 15 μg/mL Cisplatin. (b)–(d) Densitometric analysis of the western blot transfer data of the proteins. The significant difference with values of p < 0.0001. Different letters indicate statistically significant differences between each treatment with p ≤ 0.0001.